M
Molecular Health
Software solutions for evidence-based healthcare decision support and smarter drug development
About Molecular Health
Molecular Health operates in the precision medicine sector, providing advanced software solutions that leverage artificial intelligence and molecular data to support oncology and genetic diagnostics. The company serves a diverse clientele, including physicians, laboratories, and pharmaceutical biotech companies. Its core products, such as MH Guide and ONCOCATCH, offer therapy planning, early cancer detection, and analysis of hereditary cancer syndromes. Molecular Health's business model revolves around offering subscription-based access to its software platforms, which are designed to integrate and analyze vast amounts of clinical and molecular data. This enables healthcare professionals to make evidence-based decisions, improving patient outcomes. The company generates revenue through software subscriptions, collaborations, and partnerships with healthcare institutions and biotech firms.
Source: Dealroom company dataNews
Open roles
Molecular Health in the Heidelberg ecosystem
The Molecular Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
dievini Hopp Biotech holding
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Molecular Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Molecular Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

